A solution that enhances FibroScan liver disease assessment by combining FibroScan measurements with biological markers to provide improved diagnostic and prognostic information for patients with liver disease. Available variants: FibroScan®-based Scores.
Manufactured by
Echosens China
China
Echosens, founded in 2001 and headquartered in France, is a global leader in non-invasive liver health management solutions. The company established its wholly-owned China subsidiary, Shenzhen Huibo Medical Device Co., Ltd., in 2015. Echosens pioneered Vibration-Controlled Transient Elastography (VCTE®) and Controlled Attenuation Parameter (CAP™) technologies in FibroScan® devices for assessing liver fibrosis, portal hypertension, and hepatic steatosis, with 5,600+ peer-reviewed publications and 200+ international guideline endorsements.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SHENZHEN ANQUN BIOTECH CO.,LTD.
China · 2 relevant products
Hangzhou Precision MedCare co.LTD
China · 1 relevant product
Beijing O&D Biotech Co., Ltd.
China · 1 relevant product
7 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 6 relevant matches
Hangzhou Precision MedCare co.LTD · China
An intelligent grading system based on deep learning algorithms that assists doctors and researchers in analyzing liver biopsy samples and checking liver fibrosis grades using unified data standards. The system converts traditional qualitative grading to quantitative grading, improving grading accuracy and reducing doctors' workload.
Beijing O&D Biotech Co., Ltd. · China
Chemiluminescence-based assay for detection of liver fibrosis biomarkers. Supports non-invasive assessment of hepatic fibrosis and liver disease progression. Multiple regulatory approvals across domestic and international markets.
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
A diagnostic test series for the detection and assessment of liver fibrosis in patients.
3 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products